FLC Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-5,695
| Closed | -$237K | – | 174 |
|
2024
Q2 | $237K | Hold |
5,695
| – | – | 0.06% | 151 |
|
2024
Q1 | $309K | Sell |
5,695
-273
| -5% | -$14.8K | 0.08% | 122 |
|
2023
Q4 | $306K | Sell |
5,968
-277
| -4% | -$14.2K | 0.08% | 121 |
|
2023
Q3 | $362K | Sell |
6,245
-85
| -1% | -$4.93K | 0.11% | 110 |
|
2023
Q2 | $405K | Hold |
6,330
| – | – | 0.12% | 103 |
|
2023
Q1 | $439K | Hold |
6,330
| – | – | 0.13% | 101 |
|
2022
Q4 | $455K | Sell |
6,330
-18
| -0.3% | -$1.3K | 0.14% | 101 |
|
2022
Q3 | $451K | Buy |
6,348
+18
| +0.3% | +$1.28K | 0.16% | 100 |
|
2022
Q2 | $487K | Hold |
6,330
| – | – | 0.16% | 104 |
|
2022
Q1 | $462K | Hold |
6,330
| – | – | 0.13% | 111 |
|
2021
Q4 | $395K | Hold |
6,330
| – | – | 0.11% | 123 |
|
2021
Q3 | $375K | Sell |
6,330
-141
| -2% | -$8.35K | 0.11% | 130 |
|
2021
Q2 | $432K | Buy |
6,471
+141
| +2% | +$9.41K | 0.13% | 118 |
|
2021
Q1 | $400K | Hold |
6,330
| – | – | 0.13% | 117 |
|
2020
Q4 | $393K | Hold |
6,330
| – | – | 0.13% | 106 |
|
2020
Q3 | $384K | Hold |
6,330
| – | – | 0.14% | 103 |
|
2020
Q2 | $381K | Hold |
6,330
| – | – | 0.15% | 91 |
|
2020
Q1 | $349K | Hold |
6,330
| – | – | 0.16% | 77 |
|
2019
Q4 | $406K | Hold |
6,330
| – | – | 0.16% | 70 |
|
2019
Q3 | $321K | Sell |
6,330
-2,285
| -27% | -$116K | 0.14% | 79 |
|
2019
Q2 | $394K | Buy |
+8,615
| New | +$394K | 0.16% | 77 |
|
2019
Q1 | – | Sell |
-4,015
| Closed | -$209K | – | 117 |
|
2018
Q4 | $209K | Buy |
+4,015
| New | +$209K | 0.14% | 83 |
|